University Of Santiago De Compostela

This early-phase study tests whether a new biomaterial (REGENFAST) works better than a standard platelet-based treatment (L-PRF) for repairing gum and bone damage caused by gum disease. Fifteen adults with matching defects on both sides of the mouth will receive one treatment on …